Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yantai Zhenghai Bio-tech is a prominent Chinese biotechnology company specializing in regenerative medicine and biomaterials. Established in 2003 and based in Yantai, the company develops, manufactures, and markets high-performance medical devices for tissue repair and regeneration. Its core product portfolio includes the Heal-All oral repair membrane, Bongold bone repair materials, and dural repair patches, which are widely used in dentistry, neurosurgery, and orthopedics. Zhenghai Bio-tech leverages a proprietary decellularization technology platform to produce natural scaffolds that facilitate the body's own healing processes. The company is listed on the Shenzhen Stock Exchange and is recognized as a leader in the domestic Chinese market for bio-regenerative materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhenghai Biological.